{"id":"W2106082064","doi":"10.1016/j.clml.2015.07.649","title":"Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective","year":2015,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; University of Toronto; Jewish General Hospital; McGill University; BC Cancer Agency; Princess Margaret Cancer Centre; Foothills Medical Centre","funders":"","keywords":"Ibrutinib; Obinutuzumab; Venetoclax; Idelalisib; Chemoimmunotherapy; Chronic lymphocytic leukemia; Fludarabine; Medicine; Rituximab; Ofatumumab; Oncology; Internal medicine; Cyclophosphamide; Bendamustine; Leukemia; Immunology; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001936216,0.0009871122,0.002545732,0.003916536,0.000571588,0.001940827,0.001307005,0.001844946,0.006187812],"category_scores_gemma":[0.002629,0.0003884459,0.001233477,0.004190697,0.0008629222,0.001917846,0.001106404,0.003298998,0.001467298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002729598,"about_ca_system_score_gemma":0.006120109,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01509969,"about_ca_topic_score_gemma":0.04821997,"domain_scores_codex":[0.9995903,0.00007933755,0.00006427844,0.00006120228,0.0001432142,0.00006170323],"domain_scores_gemma":[0.9983377,0.000782515,0.0001648641,0.00002627192,0.0005529543,0.0001356992],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002820079,0.00008586251,0.0002424799,0.0413814,0.0003253857,0.0002056194,0.0000974994,0.0004667055,0.0009095899,0.006594111,0.1110372,0.8383722],"study_design_scores_gemma":[0.0001114889,0.0001109341,0.0005994661,0.01359094,0.0004854331,0.0003307169,0.00007907548,0.00008260267,0.0001107638,0.00172219,0.9827524,0.00002390891],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002051976,0.9990129,0.00002107982,0.0004143222,0.0001780097,0.000002460856,0.00001497587,0.000002428336,0.0003332632],"genre_scores_gemma":[0.0002453253,0.9989096,0.00006644557,0.0004340997,0.0001459417,0.000002765001,0.00001598534,7.25221e-7,0.0001791282],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9849003,"threshold_uncertainty_score":0.03002363,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1468459377124565,"score_gpt":0.4434761803015968,"score_spread":0.2966302425891403,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}